Working… Menu

A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00736372
Recruitment Status : Completed
First Posted : August 15, 2008
Last Update Posted : May 17, 2018
Information provided by (Responsible Party):
Seagen Inc. ( Cascadian Therapeutics Inc. )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2009
Actual Study Completion Date : August 2009